Role of P-glycoprotein in ocular clearance of rhodamine 123 in rabbits

Pharmaceutical Research

Volumn 17, Issue 4, 2000, Pages 479-481

  Kajikawa, Tetsu ^a   Mishima, Hiromu K ^a   Murakami, Teruo ^a   Takano, Mikihisa ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood aqueous barrier; Cyclosporin A; Ocular clearance; P glycoprotein; Quinidine; Rhodamine 123

Indexed keywords

CARRIER PROTEIN; CYCLOSPORIN A; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GLYCOPROTEIN P; QUINIDINE; RHODAMINE;

ANIMAL EXPERIMENT; AQUEOUS HUMOR FLOW; ARTICLE; BLOOD EYE BARRIER; CONTROLLED STUDY; DRUG CLEARANCE; DRUG ELIMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; OSMOLARITY; PH; PRIORITY JOURNAL; RABBIT;

ANIMALS; CYCLOSPORINE; EYE; MALE; P-GLYCOPROTEIN; RABBITS; RHODAMINE 123;

EID: 0034082164     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007593407570     Document Type: Article

References (15)

1. 1. R. D. Schoenwald. Ocular drug delivery. Pharmacokinetic considerations. Clin. Pharmacokinet. 18:255-269 (1990).
2. 2. J. A. Holash and P. A. Stewart. The relationship of astrocyte-like cells to the vessels that contribute to the blood-ocular barriers. Brain Res. 629:218-224 (1993).
3. 3. J. Wu, J. J. Zhang, H. Koppel, and T. J. Jacob. P-glycoprotein regulates a volume-activated chloride current in bovine non-pigmented ciliary epithelial cells. J. Physiol. Lond. 15 :743-755 (1996).
4. 4. R. O. Schlingemann, P. Hofman, J. Klooster, H. G. Blaauwgeers, R. Van-der-Gaag, and G. F. Vrensen. Ciliary muscle capillaries have blood-tissue barrier characteristics. Exp. Eye Res. 66:747-754 (1998).
5. 5. F. Thiebaut, T. Tsuruo, H. Hamada, M. M. Gottesman, I. Pastan, and M. C. Willingham. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA. 84:7735-7738 (1987).
6. 6. E. G. Scuetz, W. T. Beck, and J. D. Schuetz. Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol. Pharmacol. 49:311-318 (1996).
7. 7. J. S. Lee, K. Paull, M. Alvaroz, C. Hose, A. Monks, M. Grever, A. T. Fojo, and S. E. Bates. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Mol. Pharmacol. 46:627-638 (1994).
8. 8. T. Kajikawa, H. K. Mishima, T. Murakami, and M. Takano. Role of P-glycoprotein in distribution of rhodamine 123 into aqueous humor in rabbits. Curr. Eye Res. 18:240-246 (1999).
9. 9. M. P. Langford, M. E. Berg, J. H. Mack, J. P. Ganley, and T. C. Welbourne. Inhibition of glutamate uptake causes an acute increase in aqueous humor protein. Exp. Eye Res. 64:157-165 (1997).
10. 10. Q. Wang, H. Yang, D. W. Miller, and W. F. Elmquist. Effect of the p-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: an in vivo microdialysis study in freely moving rats. Biochem. Biophys. Res. Commun. 211:719-726 (1995).
11. 11. C. H. Chiang and R. D. Schoenwald. Ocular pharmacokinetic models of clonidine-3H hydrochloride. J. Phamacokinet. Biopharm. 14:175-211 (1986).
12. 12. R. D. Schoenwald and D. S. Chien. Ocular absorption and disposition of phenylephrine and phenylephrine oxazolidine. Biopharm. Drug Dispos. 9:527-538 (1988).
13. 13. K. J. Himmelstein, I. Guvenir, and T. F. Patton. Preliminary pharmacokinetic model of pilocarpine uptake and distribution in the eye. J. Pharm. Sci. 67:603-606 (1978).
14. 14. R. F. Jones and D. M. Maurice. New methods of measuring the rate of aqueous flow in man with fluorescein. Exp. Eye Res. 5:208-220 (1966).
15. 15. J. M. Conrad and J. R. Robinson. Aqueous chamber drug distribution volume measurement in rabbits. J. Pharm. Sci. 66: 219-224 (1977).